ASX 200 Trade Table Closes Coles Group (COL.ASX) for Profit
Abbott Laboratories
ABT:NYS is a new position opened in the US S&P 100 Trade Table.
The entry price for this position is $127.96.
Abbott Laboratories is a global healthcare company engaged in the discovery, development, manufacture, and sale of a diversified range of health care products, including cardiovascular and diabetes devices, nutritional products, diagnostic equipment, and branded generic drugs.

New Trade Alert: INTC Added to S&P 100 Trade Table
NYS:INTC is under Algo Engine buy conditions.
Our ‘Trade Table S&P 100 Trade Table’ model portfolio has initiated a new long position.
We have bought shares of Intel Corporation (INTC.NAS) at an entry price of $21.53.
Intel is a foundational company in the semiconductor industry, known for designing and manufacturing microprocessors for personal computers and data centers. It pioneered the x86 architecture and has been a key driver of Moore’s Law.

Trade Table ASX 200 Model Opens Position in A2 Milk Company
The A2 Milk Company We’ve initiated a new position in our Trade Table ASX 200 model portfolio today, buying shares in The A2 Milk Company Limited (A2M.ASX).
The position was opened with an entry price of $8.0100.
The A2 Milk Company focuses on dairy nutritional products, particularly known for milk and infant formula containing only the A2 beta-casein protein type, which some consumers find easier to digest compared to conventional milk containing both A1 and A2 proteins.

There are new Signals.
For our Members, please find below the latest list of signals.
There are new Signals.
For our Members, please find below the latest list of signals.
There are new Signals.
For our Members, please find below the latest list of signals.
There are new Signals.
For our Members, please find below the latest list of signals.
There are new Signals.
For our Members, please find below the latest list of signals.
Send our ASX Research to your Inbox
Or start a free thirty day trial for our full service, which includes our ASX Research.